Insider Trading activities of Dipexium Pharmaceuticals, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Dipexium Pharmaceuticals, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Dipexium Pharmaceuticals, Inc. since year 2005. Table 2 shows the detailed insider transactions of Dipexium Pharmaceuticals, Inc. since 2005. The reporting company's ticker symbol is PLXP. The reporting company's CIK number is 1497504.
The total value of stock buying since 2005 is $656,979.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Dipexium Pharmaceuticals, Inc. (PLXP).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-06 69,091 $474,999 0 $0 0 $0
2014-05 3,000 $27,000 0 $0 0 $0
2014-03 12,915 $154,980 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Dipexium Pharmaceuticals, Inc. insiders (PLXP)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-06-14 Valentino Michael J (Executive Chairman) Buy 29,091 6.88 200,000
2017-06-14 Jorden David Emerson (Acting Chief Financial Officer) Buy 32,727 6.88 224,998
2017-06-14 Mossman Gary L (Chief Operating Officer) Buy 7,273 6.88 50,001
2014-05-21 Dean Jack H (Director) Buy 3,000 9.00 27,000
2014-03-18 Shawah Robert G. (Chief Accounting Officer) Buy 500 12.00 6,000
2014-03-18 Garrett David (VP, Finance & Corp. Dev.) Buy 2,083 12.00 24,996
2014-03-18 Dean Jack H (Director) Buy 2,083 12.00 24,996
2014-03-18 Luci David P (President, CEO, Secretary) Buy 2,083 12.00 24,996
2014-03-18 Harrison Thomas L (Director) Buy 2,000 12.00 24,000
2014-03-18 Deluccia Robert J (Executive Chairman) Buy 2,083 12.00 24,996
2014-03-18 Coughlin Christopher J (Director) Buy 2,083 12.00 24,996

Insider trading activities including stock purchases, stock sales, and option exercises of PLXP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Dipexium Pharmaceuticals, Inc. (symbol PLXP, CIK number 1497504) see the Securities and Exchange Commission (SEC) website.